Credit Suisse Additional Tier 1 (AT1) Capital Notes
Credit Suisse Additional Tier 1 (AT1) Capital Notes
In March 2023, Swiss authorities engineered an emergency takeover of Credit Suisse by UBS, resulting in the complete write-down of roughly around $17 billion in Credit Suisse Additional Tier 1 (AT1) capital notes. For thousands of investors—including retail and high-net-worth buyers in the United States—the shock was immediate and severe: bonds were wiped out to zero while common shareholders still walked away with roughly CHF 3 billion in UBS stock.
Years after the collapse, the legal fallout continues across courts and arbitration panels. In October 2025, the Swiss Federal Administrative Court issued a landmark partial ruling declaring FINMA’s write-off decree unlawful, and U.S. federal courts have allowed securities class actions involving Credit Suisse securities to move forward. Yet for individual U.S. investors who bought these notes through a brokerage firm, FINRA arbitration remains a primary, direct avenue to pursue recovery when a broker failed to disclose the true risks of the product.
Additional Tier 1 bonds—often called contingent convertible bonds or "CoCos"—were created after the 2008 financial crisis so large banks could absorb losses during severe stress without relying on taxpayer bailouts. They typically pay higher yields than traditional senior bonds to compensate for risk, but carry strict contractual triggers tied to capital ratios or regulatory "viability events."
Several features of the Credit Suisse write-down caught investors off guard:
Inverted loss hierarchy: Investors generally expect common equity shareholders to absorb losses before bondholders. In the March 2023 rescue, AT1 holders were wiped out completely while equity holders received value in UBS shares.
Emergency write-down mechanics: FINMA ordered the full write-down in connection with extraordinary state liquidity assistance and the emergency UBS merger, a move later challenged and overturned in part by the Swiss Federal Administrative Court in October 2025.
Complex, asymmetric downside: Unlike standard fixed-income securities where principal is returned at maturity unless the issuer defaults, AT1 notes can be permanently written down to zero even while equity retains value.
The harm to investors went beyond market volatility. Many individuals held Credit Suisse AT1 notes expecting steady income and capital preservation relative to stocks, only to suffer a permanent loss of principal overnight.
Common ways investors were harmed include:
Total principal wipeout: Bondholders lost 100% of the written-down par value of affected AT1 notes, with no maturity date to wait out a recovery.
Unsuitable concentration: Investors looking for conservative or moderate income sometimes had significant portions of retirement or liquid savings placed into high-risk, complex contingent capital instruments.
Incomplete risk explanations: Technical terms like "viability event," "write-down," and "subordination" were often glossed over in sales pitches that focused on yield and Credit Suisse’s status as a major global bank.
While overseas litigation and U.S. class actions target issuers, regulators, or broader market misstatements, FINRA arbitration focuses on the relationship between you and the brokerage firm or financial advisor that sold you the investment.
Most U.S. brokerage account agreements require disputes with broker-dealers to be resolved through Financial Industry Regulatory Authority (FINRA) arbitration rather than court. Unlike a class action—where individual circumstances are grouped together and payouts may be diluted—FINRA arbitration is an individual claim centered on how your specific account was handled.
Investors pursuing FINRA arbitration over Credit Suisse AT1 losses typically evaluate claims such as:
Unsuitability / Reg BI violations: Under FINRA suitability rules and the SEC’s Regulation Best Interest (Reg BI), brokers must have a reasonable basis to believe a recommended security fits a retail customer’s investment profile, risk tolerance, time horizon, liquidity needs, and financial situation.
Misrepresentations and omissions: If an advisor downplayed write-down risk, equated AT1 notes with conventional investment-grade bonds, or failed to explain how viability triggers work, that omission or misstatement can support a claim.
Overconcentration: Putting an outsized share of a conservative or income-focused portfolio into a single complex foreign bank instrument can violate diversification and risk-management standards.
Failure to supervise: Brokerage firms have a legal duty to supervise advisors, review complex product sales, and enforce internal compliance controls.
If you lost money on Credit Suisse AT1 capital notes through a U.S. brokerage account, taking organized steps early helps protect your rights:
Gather account and trade records: Collect monthly statements, trade confirmations, account profiles/risk questionnaires, and any emails, notes, or marketing materials from your advisor.
Review your investment profile and timeline: Note your stated risk tolerance when the trade occurred, your need for liquidity, and how large the AT1 position was relative to your net worth and liquid portfolio.
Watch filing deadlines: FINRA arbitration generally has a six-year eligibility rule from the occurrence or event giving rise to the claim, though state statutes of limitations or specific contractual provisions can affect timing.
Contact our firm or another experienced securities arbitration attorney: Because FINRA rules, discovery, and damages calculations (such as out-of-pocket losses and well-managed portfolio comparisons) are specialized, speaking with counsel experienced in FINRA investor claims can clarify whether your facts support a viable case.
November 20, 2026